Stablix, Inc. (@StablixInc) header
Stablix, Inc. (@StablixInc) profile picture

Pioneering transformative medicines for targeted deubiquitination therapeutics (TPT)

New York, NY and Boston, MA
Joined June 2021
Photo by Stablix, Inc. (@StablixInc)Photo by Stablix, Inc. (@StablixInc)Photo by Stablix, Inc. (@StablixInc)
Check out the @WuXi_AppTec “BOLD: Innovation That Matters” event happening today. Hear from our CSO @EddineSaiah on how we’re expanding the definition of druggability by unlocking the power of targeted protein #deubiquination. Tune in: wxpress.wuxiapptec.com/detai… #TakingBOLDAction
1
2
384
How are we #TakingBOLDAction to pioneer targeted protein #deubiquitination therapeutics? Tomorrow, Chief Scientific Officer @EddineSaiah will share how we're aiming to redefine #druggability during @WuXi_AppTec’s “BOLD: Innovation That Matters." Register: wxpress.wuxiapptec.com/detai…
2
3
352
We’re thrilled to announce our collaboration with @VertexPharma to discover & develop #TPS (targeted protein stabilization) therapeutics. Learn how we’re exploring the potential of targeted protein #deubiquitination for patients in need of breakthroughs: stablix.com/stablixandvertex…
2
1
7
546
Our COO and co-founder, Kevin Sprott, is thrilled to speak in a panel discussion at the #wellsfargo 2023 Targeted Protein Degradation (#TPD) Virtual Summit tomorrow (2p EST), as we establish a new paradigm for restoring protein function. tinyurl.com/5328duvj
1
180
Exciting start to the week. We are thrilled to welcome Tony Kingsley!
1
Stablix, Inc. retweeted
Versant-backed Stablix has launched to use heterobifunctional moecules to tap into the ubiquitin-proteasome system--but they're not crunching down proteins, they're trying to restore their function. My story: cen.acs.org/pharmaceuticals/…